Bank of New York Mellon »

Apogee Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.6M 113k 58.74
2024-06-30 $5.3M 136k 39.35
2024-03-31 $9.1M 137k 66.45
2023-12-31 $1.8M 66k 27.94
2023-09-30 $1.3M 60k 21.30